B
ICCC icon

Bailard’s ImmuCell ICCC Stock Holding History

Bailard’s Portfolio ICCC Stock Details ICCC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$102K Hold
10,102
– – ﹤0.01% 758
2026
Q1 		$63.9K Buy
+10,102
New +$64.7K ﹤0.01% 734

Other funds holding ICCC

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
CAM
Cresset Asset Management Chicago, Illinois $27.6B AUM 31.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
BL
Bleichroeder LP New York $559M AUM 83.7% 1-Year Est. Return
S
Steadtrust Allen, Texas $198M AUM 99.37% 1-Year Est. Return
MFIM
Mesirow Financial Investment Management Chicago, Illinois $6.37B AUM 23.22% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Bailard's ICCC Position: Q2 2026 in Review

Bailard held its ImmuCell (ICCC) position steady in Q2 2026 at 10,102 shares worth $102K. The position accounts for ﹤0.01% of the portfolio, ranked #758.

Bailard first reported a position in ICCC in Q1 2026 and has held it in 2 quarters since. 31 funds tracked by Wall St. Rank hold ICCC as of Q2 2026.

  • Bailard held 10,102 shares of ImmuCell worth $102K as of Q2 2026.
  • Bailard left its ImmuCell share count unchanged in Q2 2026.
  • ImmuCell made up ﹤0.01% of Bailard's portfolio in Q2 2026, its #758 holding.
  • Bailard first reported a position in ImmuCell in Q1 2026 and has held it in 2 quarters since.
  • 31 funds tracked by Wall St. Rank held ImmuCell as of Q2 2026.

Based on Bailard's 13F filing for Q2 2026, filed 30 Jul 2026.